Humberto Muzi Filho is a researcher and specialist in the fields of Physiology and Pharmacology, based in Rio de Janeiro, Brazil. He holds a Ph.D. in Pharmacology and has built a solid career in biomedical research, combining advanced expertise in cellular physiology with the principles of precision medicine. His scientific investigations are primarily focused on elucidating the complex molecular mechanisms that underlie the genesis and progression of hypertension and cardiorenal syndrome, particularly when these conditions are associated with metabolic disorders. Throughout his academic trajectory, which includes active and extensive postdoctoral research, he has dedicated his efforts to understanding cell signaling pathways, ion transport, and homeostatic imbalances that drive cardiovascular and renal diseases. By bridging the gap between basic science and clinical relevance, his work aims to identify novel biomarkers and specific therapeutic targets. The ultimate goal of his research is to contribute to the development of more effective, individualized medical treatments, advancing the strategies of precision medicine to improve patient outcomes in complex metabolic and cardiovascular profiles.